Cencora Business Update
Cencora, Inc. announced a reorganization of its operating model and reporting structure to advance growth priorities and improve visibility. Beginning in fiscal 2027, the company will report results across three segments: Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other. The filing includes supplemental unaudited historical segment data for fiscal 2025 and 2026 recast under this new structure to assist investor analysis.